Acne Vulgaris
Conditions
Keywords
Asprosin
Brief summary
Subject of interest is to evaluate serum level of asprosin in male patients with acne vulgaris, demonstrate the relation between acne vulgaris severity and level of asprosin in these patients & the relation between metabolic syndrome in acne vulgaris and level of asprosin.
Interventions
assessment of serum asprosin by a commercially available double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) kit.
Sponsors
Study design
Eligibility
Inclusion criteria
* Acne vulgaris male patients (\>18 years) will be included.
Exclusion criteria
* Age \<18 years. * Females. * Patients with other inflammatory skin disorders. * Patients with associated systemic diseases. * Current or previous treatment with isotretinoin in the last 3 month ,anti-inflammatory drugs, systemic antibiotics, androgen or anti androgen therapy, and steroid therapy). * Patients known on treatment of diabetes, hypertension and dyslipidemia. * Athletes. * Patient refusal.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Assess serum asprosin level in male patients with acne vulgaris. | 6 months | Assess serum asprosin level in male patients with acne vulgaris. |
Countries
Egypt